AURO LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Auro Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.09₹ 5.20
As on Dec 12, 2025, 4:01 PM IST
Auro Laboratories Price Performance
Today's LowToday's High
₹246.00₹255.00
₹253.50
52 Weeks' Low52 Weeks' High
₹0.00₹0.00
₹253.50
Open Price
₹252.00
Prev. Close
₹248.30
Volume
1,711
Over the last 5 years, the share price of Auro Laboratories has gained 24.77% CAGR. Over the past year, the corresponding return has been 7.48%.
Auro Laboratories’s current P/E of 149.73x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Auro Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Auro Laboratories | -0.96 | 15.54 | 4.97 | -7.19 | 10.12 | 50.92 | 24.77 |
| Sun Pharmaceutical Industries | -0.58 | 3.38 | 11.99 | 6.27 | -1.06 | 22.05 | 25.52 |
| Divi's Laboratories | -0.91 | -2.66 | 5.98 | -3.83 | 9.16 | 24.33 | 12.25 |
| Torrent Pharmaceuticals | -0.04 | -1.19 | 7.02 | 16.28 | 12.92 | 32.76 | 22.85 |
| Cipla | -0.36 | -0.7 | -2.12 | 0.65 | 4.68 | 11.36 | 13.93 |
| Dr. Reddy's Laboratories | 0.35 | 3.64 | -1.64 | -6.02 | 2.66 | 12.85 | 4.96 |
| Lupin | 0.68 | 2.88 | 3.18 | 5.58 | 1.76 | 41.12 | 17.54 |
| Zydus Lifesciences | -0.33 | -1.68 | -10.45 | -4.78 | -5.11 | 31.8 | 14.59 |
| Mankind Pharma | -1.57 | -3.81 | -16 | -8.9 | -17.81 | 15.07 | 8.79 |
| Aurobindo Pharma | -2.22 | -1.53 | 8.35 | 3.45 | -1.45 | 38.17 | 6.01 |
| Alkem Laboratories | -1.1 | -1.67 | 2.31 | 16.06 | 4.66 | 21.78 | 13.95 |
| Abbott India | -3 | -5.25 | -9.45 | -11.23 | -2.29 | 10.93 | 11.17 |
| Glenmark Pharmaceuticals | 0.03 | 4.79 | -6.32 | 17.76 | 29.6 | 66.62 | 30.17 |
| Laurus Labs | -1.25 | 1.61 | 13.32 | 51.9 | 76.76 | 35.86 | 25.27 |
| Biocon | -1.74 | -7.46 | 7.67 | 8.58 | 9.43 | 12.64 | -3.18 |
| GlaxoSmithKline Pharmaceuticals | 2.12 | 4.15 | -5.73 | -21.28 | 15.2 | 24.97 | 10.89 |
| Anthem Biosciences | 6.53 | -0.25 | -16.56 | -4.63 | -4.63 | -1.57 | -0.94 |
| Ipca Laboratories | 0.05 | 12.08 | 11.44 | 6.8 | -4.85 | 19.25 | 5.57 |
| Ajanta Pharma | 0.81 | 4.4 | 4.33 | 0.92 | -5.22 | 29.75 | 18.87 |
| J B Chemicals & Pharmaceuticals | -1.42 | -1.17 | 7.09 | 3.81 | -2.33 | 20.44 | 28.62 |
Over the last one year, Auro Laboratories has gained 10.12% compared to peers like Sun Pharmaceutical Industries (-1.06%), Divi's Laboratories (9.16%), Torrent Pharmaceuticals (12.92%). From a 5 year perspective, Auro Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.52%) and Divi's Laboratories (12.25%).
Auro Laboratories Financials
Auro Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 245.39 | 242.74 |
| 10 | 248.03 | 244.12 |
| 20 | 242.54 | 238.87 |
| 50 | 223.24 | 231.9 |
| 100 | 237.44 | 234.79 |
| 200 | 243.58 | 235.83 |
Auro Laboratories Share Holding Pattern
In the latest quarter, Auro Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.01%, FII holding unchanged at 0.00%, and public shareholding unchanged at 47.82% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Auro Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 13, 2025, 2:59 AM IST | Auro Labs - Grant Of 'Certificate Of Good Manufacturing Practices' From World Health Organisation ('WHQ"). |
| Nov 13, 2025, 12:41 AM IST | Auro Labs - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025 |
| Nov 13, 2025, 12:31 AM IST | Auro Labs - Board Meeting Outcome for Outcome Of The Board Meeting Dated November 12, 2025 |
| Nov 07, 2025, 12:38 AM IST | Auro Labs - Board Meeting Intimation for Unaudited Financial Results Of The Company For Quarter And Half Year Ended September |
| Oct 14, 2025, 2:39 AM IST | Auro Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Auro Laboratories
Auro Laboratories Ltd. is a Public Limited Listed company incorporated on 26/05/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L33125MH1989PLC051910 and registration number is 051910. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19.40 Cr. and Equity Capital is Rs. 6.23 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressK-56, M.I.D.C. Industrial Area, Palghar District Maharashtra 401506
- Contact
Management
- Mr. Sharat DeorahChairman & Managing Director
- Mr. Kiran Suresh KulkarniWhole Time Director
- Mr. Siddhartha DeorahWhole Time Director
- Mr. Mahendra Kumar DagaInd. Non-Executive Director
- Mrs. Kavita Vijayakant SharmaInd. Non-Executive Director
- Mr. Vishal Kailashchandra JhunjhunwalaInd. Non-Executive Director
FAQs on Auro Laboratories Share Price
What is the share price of Auro Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Auro Laboratories is ₹253.50 as on Dec 12, 2025.
What kind of stock is Auro Laboratories?
The Auro Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Auro Laboratories?
The market cap of Auro Laboratories is ₹157.99 Cr as on Dec 12, 2025.
What are today's High and Low prices of Auro Laboratories?
Today’s highest and lowest price of Auro Laboratories are ₹255.00 and ₹246.00.
What are the 52 Week High and 52 Week Low of Auro Laboratories?
The 52-week high/low is the highest and lowest price at which Auro Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Auro Laboratories is ₹0.00 and 52-week low of Auro Laboratories is ₹0.00 as on Dec 12, 2025.
How has the Auro Laboratories performed historically in terms of returns?
The Auro Laboratories has shown returns of 2.09% over the past day, 38.64% for the past month, 5.71% over 3 months, 7.48% over 1 year, 50.92% across 3 years, and 24.77% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Auro Laboratories?
P/E ratio of and PB ratio of Auro Laboratories are 149.73 and 3.68 on Dec 12, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse